FutureChem Co.,Ltd

Research FutureChem Co.,Ltd (220100.KQ) on Bullrun: market cap KRW 188.00B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 188.00B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 188.00Bn/an/an/a

Dividend history

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

Dongwha Pharm.Co.,Ltd (000020.KS) Yuhan Corporation (000100.KS) Yuyu Pharma, Inc. (000220.KS) Ildong Holdings Co., Ltd. (000230.KS) Samil Pharmaceutical Co.,Ltd (000520.KS) Dong-A Socio Holdings Co., Ltd. (000640.KS) JW Pharmaceutical Corporation (001060.KS) SAMSUNG PHARM. Co., LTD. (001360.KS) Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) Chong Kun Dang Holdings Corp. (001630.KS) Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) HANDOK Inc. (002390.KS)

Frequently asked questions

What is FutureChem Co.,Ltd's market cap?

FutureChem Co.,Ltd's market capitalization is KRW 188.00B.

What does FutureChem Co.,Ltd do?

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis.